Blueshift Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
CAM
RIM
Blueshift Asset Management's LMAT Position: Q2 2025 in Review
Blueshift Asset Management sold out of LeMaitre Vascular (LMAT) in Q2 2025, closing a stake of 2,769 shares — an estimated $232K sold.
Blueshift Asset Management first reported a position in LMAT in Q1 2025 and held it in 1 quarter. The position peaked at $232K in Q1 2025. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.
- Blueshift Asset Management reported no remaining LeMaitre Vascular position as of Q2 2025 after selling out during the quarter.
- Blueshift Asset Management sold 2,769 LeMaitre Vascular shares in Q2 2025, an estimated $232K.
- Blueshift Asset Management first reported a position in LeMaitre Vascular in Q1 2025 and held it in 1 quarter.
- Blueshift Asset Management's LeMaitre Vascular position peaked at $232K in Q1 2025.
- 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.
Based on Blueshift Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.